Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Mangoceuticals
MGRX
$8.45M
| $31K | ﹤0.01% |
+8,755
| New | +$41.3K |
|
|
CTHR
4352
DELISTED
Charles & Colvard Ltd
CTHR
| $30.4K | ﹤0.01% |
17,351
-1,939
| -10% | -$3.4K |
|
4353
New Concept Energy
GBR
$3.51M
| $29.7K | ﹤0.01% |
25,818
-3,360
| -12% | -$4.66K |
|
4354
Cheche Group
CCG
$35.2M
| $29.5K | ﹤0.01% |
927
| – | – |
|
4355
Energy Focus
EFOI
$20.3M
| $29.3K | ﹤0.01% |
24,651
+6,020
| +32% | +$8.26K |
|
|
PRHI
4356
Presurance Holdings
PRHI
$17.2M
| $28.8K | ﹤0.01% |
3,771
+1,238
| +49% | +$8.15K |
|
|
ENSV
4357
DELISTED
Enservco Corp.
ENSV
| $28.5K | ﹤0.01% |
218,892
+57,283
| +35% | +$9.63K |
|
4358
Hour Loop
HOUR
$68.3M
| $28.4K | ﹤0.01% |
19,584
| – | – |
|
|
FAAS
4359
DELISTED
DigiAsia
FAAS
| $28.3K | ﹤0.01% |
14,528
-10,183
| -41% | -$21.8K |
|
4360
Moving iMage Technologies
MITQ
$5.42M
| $28.3K | ﹤0.01% |
49,623
-865
| -2% | -$532 |
|
|
ZSQR
4361
Z Squared Inc
ZSQR
$213M
| $27.7K | ﹤0.01% |
7,689
-2,254
| -23% | -$10.1K |
|
|
NBP
4362
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $27.3K | ﹤0.01% |
22,037
-12,310
| -36% | -$15.4K |
|
4363
Processa Pharmaceuticals
PCSA
$7.11M
| $27K | ﹤0.01% |
788
+99
| +14% | +$3.88K |
|
4364
OLB
OLB
$4.49M
| $26.8K | ﹤0.01% |
+10,127
| New | +$24.6K |
|
4365
Professional Diversity Network
IPDN
$5.39M
| $26.8K | ﹤0.01% |
6,094
+566
| +10% | +$2.68K |
|
4366
Milestone Pharmaceuticals
MIST
$152M
| $26.7K | ﹤0.01% |
17,576
| – | – |
|
4367
CNS Pharmaceuticals
CNSP
$7.86M
| $26.5K | ﹤0.01% |
+339
| New | +$97.2K |
|
4368
Peraso
PRSO
$11.3M
| $26.5K | ﹤0.01% |
19,059
+5,347
| +39% | +$7.58K |
|
|
KUST
4369
Kustom Entertainment Inc
KUST
$759K
| $26.2K | ﹤0.01% |
1
| – | – |
|
|
QCLS
4370
Q/C Technologies Inc
QCLS
$22.9M
| $25.9K | ﹤0.01% |
160
+16
| +11% | +$2.77K |
|
4371
Arts-Way Manufacturing Co
ARTW
$11.4M
| $25.8K | ﹤0.01% |
14,022
-5,323
| -28% | -$8.92K |
|
4372
Onfolio Holdings
ONFO
$303K
| $25.7K | ﹤0.01% |
23,817
-337
| -1% | -$323 |
|
4373
Twin Vee PowerCats
VEEE
$4.85M
| $25.5K | ﹤0.01% |
115
+15
| +15% | +$2.81K |
|
4374
Iveda Solutions
IVDA
$3.54M
| $25.3K | ﹤0.01% |
15,070
+2,426
| +19% | +$7.52K |
|
|
YI
4375
111 Inc
YI
$34.5M
| $25K | ﹤0.01% |
3,310
| – | – |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.